Aortorenal Bypass with Autologous Saphenous Vein in Takayasu Arteritis-induced Renal Artery Stenosis

Abstract

Our data suggest that ARB with autologous saphenous vein graft is safe, effective and durable in treating TARAS.

Impact of revascularization on hypertension in children with Takayasu’s arteritis-induced renal artery stenosis: a 21-year review

“…Overall, revascularization (both surgical and endovascular) was beneficial to BP control in the majority (53 %) of our patients. This positive effect of revascularization is in agreement with previous studies describing the benefits of revascularization procedures in terms of preservation of renal function and treatment of hypertension in adults and children with TA [5,8,11,12,21,[23][24][25][26][27][28][29][30]. Most previous studies on the outcome of renal revascularization on RVH in children originate from the Western world and report success rates of between 85 and 95 % [6][7][8][9][10]31].…”

Renal artery stenting may not be appropriate for patients with atherosclerotic renal artery stenosis

“…A primary patency of 75% was identified in the literature and used for aortorenal bypass patients who developed complications to determine whether this significantly influenced cost or value for aortorenal bypass compared to renal artery stenting, but none was found (Figure 2). 18,19 Similarly, a maximum five-year secondary patency of 87% was used for renal artery stent patients, but no significant difference in cost or value was found. 19 A composite endpoint of dialysis and death from all causes was used and as a basis of comparison to patients who were alive and dialysis-free at five years.…”

“…Five-year patency following aortorenal bypass is 95.0%, compared to 55.6% for renal artery stenting. 7,10,[18][19][20] The five-year patency was assumed to be similar between patients who had no complications and those who experienced one or more complications. A primary patency of 75% was identified in the literature and used for aortorenal bypass patients who developed complications to determine whether this significantly influenced cost or value for aortorenal bypass compared to renal artery stenting, but none was found (Figure 2).…”

“…Variability in inpatient mortality, incidence of complications, five-year patency, five-year mortality, and five-year dialysis-free survival was introduced using reference values from the literature. 5,7,10,12,[18][19][20][21][22][23][24][25][26][27] Variation in life expectancy was introduced using reference values in the literature and the US Census Bureau. 10,19,21 Normal distribution plots were generated from a variance-based sensitivity analysis of these factors for cost (Figure 2a …”

Renal Autotransplantation with Autologous Saphenous Vein Graft in a Patient with Takayasu Arteritis and Existing Renal Artery Stent in Her Solitary Kidney

“…Feng et al [5] reported the results of 33 patients treated by aortorenal bypass with autologous saphenous veins. In the 5-year follow-up, the patient's blood pressure lowered and anti-hypertensive medication dosage was reduced significantly.…”